Active	Status	Sponsor type	Region	Phase	Filter
3 Active 5 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Yu, Zhiyong
NCT03703427: Capecitabine Versus Vinorelbine in High Risk Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy	Not yet recruiting	2	200	RoW	Capecitabine, Oral, 500 Mg, Vinorelbine Tartrate Oral	Zhiyong Yu	Pathologic Residual Cancer Cells	11/23	11/25
NCT04143906: Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast Cancer	Not yet recruiting	2	200	NA	Vinorelbine, Gemcitabine, Carboplatin	Shandong Cancer Hospital and Institute	Metastatic Breast Cancer	12/24	12/24
NCT04568941: Comparison Study of Different Tumor Biopsy Method for Sentinel Lymph Node Biopsy in Breast Cancer	Not yet recruiting	N/A	600	RoW	Vacuum-Assisted Biopsy, Core Needle Biopsy, Intraoperative Excisional Biopsy	Shandong Cancer Hospital and Institute	Breast Cancer, Sentinel Lymph Node	05/21	06/21